What does the research say about double cardio-renal-metabolic disease?

Double cardio-renal-metabolic disease

There is 1 paper on double cardio-renal-metabolic disease in aging research: 1 observational study in people.

1 paper studies it1 finding

“AIP-BRI was significantly associated with the progression of CRM diseases in fully adjusted model”

Aip-bri

upin humans1HR 1.18

1 study

Aip-bri is linked with a higher risk of double cardio-renal-metabolic disease in humans (fully adjusted model; progression from first CRM disease to double CRM disease) (HR 1.180 (95% CI 1.167–1.193)).
“AIP-BRI was significantly associated with the progression of CRM diseases in fully adjusted model”
Humansfully adjusted model; progression from first CRM disease to double CRM diseasemedian follow-up 12.7 years
Dynamic interplay of atherogenic index and body roundness in cardio-renal-metabolic disease: a multi-state analysis
BMC public healthDec 18, 2025

1 paper in 12 months

BMC Public HealthDec 19

Cohort study of 398,689 peopleBiomarkers